Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 251,226,896
  • Shares Outstanding, K 6,377,936
  • Annual Sales, $ 70,874 M
  • Annual Income, $ 9,402 M
  • EBIT $ 0 M
  • EBITDA $ 19,129 M
  • 60-Month Beta 0.46
  • Price/Sales 3.69
  • Price/Cash Flow 12.05
  • Price/Book 6.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/06/25
  • Annual Dividend & Yield 0.87 (2.22%)
  • Most Recent Dividend 0.873 on 03/28/25
  • Sector Medical
  • INDUSTRY GROUPING Large Cap Pharma

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.0700 +12.32%
on 05/15/25
41.6700 -5.47%
on 05/05/25
+0.5900 (+1.52%)
since 04/21/25
3-Month
34.7500 +13.35%
on 04/09/25
44.3100 -11.10%
on 03/17/25
-2.0300 (-4.90%)
since 02/21/25
52-Week
31.1900 +26.29%
on 05/28/24
44.3100 -11.10%
on 03/17/25
+7.0700 (+21.88%)
since 05/21/24

Most Recent Stories

More News
The Smartest Vanguard ETF to Buy With $500 Right Now

SAP : 298.16 (-0.08%)
CEG : 283.87 (-1.13%)
NVS : 111.90 (-0.78%)
RHHBY : 39.3900 (-0.81%)
AEP : 102.58 (-0.34%)
NSRGY : 106.8200 (+0.66%)
NEE : 66.92 (-6.46%)
ASML : 736.10 (-0.15%)
VOO : 534.95 (-0.15%)
VYMI : 78.31 (-0.53%)
VPU : 173.29 (-1.25%)
VGK : 75.90 (-0.62%)
Why Weight-Loss Developer Stocks Tumbled on Tuesday

VKTX : 27.01 (-0.88%)
NVO : 66.90 (-1.91%)
LLY : 713.00 (-1.65%)
RHHBY : 39.3900 (-0.81%)
RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US

Less than a month after announcing a $50 billion investment in its U.S. operations over the next five years, Swiss pharma giant Roche RHHBY has started rolling out the details of its plans.RHHBY unveiled...

JNJ : 152.87 (-0.20%)
LLY : 713.00 (-1.65%)
NVS : 111.90 (-0.78%)
RHHBY : 39.3900 (-0.81%)
Down Nearly 20%: Should You Buy the Dip on Eli Lilly?

For a while, it seemed as if Eli Lilly (NYSE: LLY) could do no wrong. Its shares skyrocketed. The company's market cap grew so much that it was within striking distance of the $1 trillion mark. Along the...

CVS : 60.04 (-3.33%)
VKTX : 27.01 (-0.88%)
NVO : 66.90 (-1.91%)
LLY : 713.00 (-1.65%)
RHHBY : 39.3900 (-0.81%)
AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth

Amgen AMGN is off to a strong start in 2025 with its first-quarter earnings as well as sales beating estimates. Particularly, its strong top-line performance caught investor attention.Amgen’s total revenues...

JNJ : 152.87 (-0.20%)
RHHBY : 39.3900 (-0.81%)
AMGN : 271.22 (-0.04%)
Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y

Alnylam Pharmaceuticals ALNY reported first-quarter 2025 adjusted loss of 1 cent per share, narrower than the Zacks Consensus Estimate of a loss of 56 cents. The company had incurred a loss of 16 cents...

ALNY : 290.13 (-0.84%)
NVS : 111.90 (-0.78%)
REGN : 603.95 (-0.11%)
RHHBY : 39.3900 (-0.81%)
Regeneron Stock Falls on Q1 Earnings and Sales Miss, Eylea Sales Down

Regeneron Pharmaceuticals, Inc. REGN reported first-quarter 2025 adjusted earnings per share (EPS) of $8.22, which missed the Zacks Consensus Estimate of $8.43. The reported figure was down 14% from $9.55...

BAYRY : 6.7000 (+0.45%)
REGN : 603.95 (-0.11%)
RHHBY : 39.3900 (-0.81%)
SNY : 52.53 (-0.70%)
Novartis Beats on Q1 Earnings and Sales, Raises Guidance, Stock Up

Swiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of 2025 and upped its annual guidance.Core earnings (excluding one-time charges) of $2.28 per share easily...

BAYRY : 6.7000 (+0.45%)
NVS : 111.90 (-0.78%)
RHHBY : 39.3900 (-0.81%)
PFE : 22.93 (-0.48%)
$4.82 Trillion in U.S. Investments Now Announced Since Start of Trump’s Presidency, 451,000 New Jobs Expected

The U.S. is experiencing an unprecedented $4.82 trillion wave of domestic and foreign investments across AI, manufacturing, healthcare, and logistics, signaling long-term confidence in America's industrial...

AAPL : 200.86 (-0.61%)
FI : 161.94 (-0.17%)
JNJ : 152.87 (-0.20%)
MRK : 77.11 (+0.17%)
ORCL : 157.10 (-0.05%)
SFTBY : 26.0000 (-1.66%)
NVS : 111.90 (-0.78%)
RHHBY : 39.3900 (-0.81%)
TSM : 191.95 (+0.10%)
DEO : 111.19 (-2.41%)
DIS : 110.78 (+0.29%)
STLA : 10.34 (-2.18%)
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion.

NVDA : 132.46 (+0.50%)
JNJ : 152.87 (-0.20%)
NVS : 111.90 (-0.78%)
RHHBY : 39.3900 (-0.81%)
TSM : 191.95 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its...

See More

Key Turning Points

3rd Resistance Point 40.2533
2nd Resistance Point 40.0767
1st Resistance Point 39.7333
Last Price 39.3900
1st Support Level 39.2133
2nd Support Level 39.0367
3rd Support Level 38.6933

See More

52-Week High 44.3100
Last Price 39.3900
Fibonacci 61.8% 39.2982
Fibonacci 50% 37.7500
Fibonacci 38.2% 36.2018
52-Week Low 31.1900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar